Skip to content

Comstock Inc. LODE Bioleum — Cash And Cash Equivalents At Carrying Value

Similar metrics at other companies

Alkermes logo
ALKSCash & Equivalents
$351.55M-12.1%
ImmunityBio, Inc. logo
IBRXCash & Equivalents
$205.19M+238%
Summit Therapeutics logo
SMMTCash & Equivalents
$8.24M+7.2%
Insmed logo
INSMCash & Equivalents
$582.19M+44.4%
Consolidated Water Company logo
CWCOBulk — Cash And Cash Equivalents At Carrying Value
$21.53M+5.1%
TG Therapeutics logo
TGTXCash & Equivalents
$442.21M+235%

Other financials

Income statement

See full
Revenue$313.5K-60.1%
Gross profit-$286.4K-184%
Operating income-$8.9M-27.1%
Net income-$9.4M-3.2%
EPS (diluted)-$3.01-450%

Balance sheet

See full
Cash & equivalents$53.0M+212%
Total debt$257.3K-98.8%
Total equity$156.4M
Total assets$218.1M+28.6%

Cash flow

See full
Operating cash flow-$5.8M-17.3%
CapEx--100%
Free cash flow-$3.5M+2.7%

Valuation

See full
Market cap$302.13M+177%
Enterprise value$249.42M+118%
P/S279.4×+247×

Profitability

See full
Gross margin-116.4%-177pp
Operating margin-3,703.7%-7,510pp
Net margin-4,010%-13,152pp
FCF margin-462.3%-171pp

Returns & leverage

See full
Return on equity-51.5%-12.9pp
Debt / equity
Current ratio4.5×+2.1×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Comstock Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Comstock Inc.'s bioleum — cash and cash equivalents at carrying value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Comstock Inc.'s bioleum — cash and cash equivalents at carrying value?
Comstock Inc. (LODE) reported bioleum — cash and cash equivalents at carrying value of $3.89M in Q1 2026.
How has Comstock Inc.'s bioleum — cash and cash equivalents at carrying value changed year-over-year?
Comstock Inc.'s bioleum — cash and cash equivalents at carrying value decreased by 45.9% year-over-year, from $7.19M to $3.89M.
What does bioleum — cash and cash equivalents at carrying value mean?
Indicates the highly liquid assets held specifically for the operational needs of the Bioleum segment. This balance reflects the segment's immediate liquidity position and its ability to fund short-term research or development activities.